Brian Kersten

Dr. Brian Kersten

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2014 in Journal of Pharmacy Practice
Verified
Journal Article
Closed access
BKBrian Kersten
Brian Kersten
MMMegan E. McLaughlin
Megan E. McLaughlin
Health care providers are seeing an increased number of patients under the influence of several new psychoactive drug classes. Synthetic cannabinoids, cathinones, and piperazines are sought by users for their psychoactive effects, perceived safety profile, minimal legal regulations, and lack of detection on routine urine drug screening. However, these drugs are beginning to be recognized by the medical community for their toxic effects. The neuropsychiatric and cardiovascular toxicities are among the most common reasons for emergency medical treatment, which in some cases, can be severe and even life-threatening. Management strategies are often limited to supportive and symptomatic care due to the limited published data on alternative treatment approaches. The purpose of this article is to offer health care providers, emergency medical personnel in particular, an awareness and understanding of the dangers related to some of the new psychoactive drugs of abuse. The background, pharmacology, toxicity, management, detection, and legal status of each class will be discussed.

1 August 2021 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
PMPatrick McGrath
Patrick McGrath
BKBrian Kersten
Brian Kersten
MCMaya R. Chilbert
Maya R. Chilbert
CRCaroline Rusch
Caroline Rusch
MNMegan Nadler
Megan Nadler

1 December 2020 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
EBEinas Batarseh
Einas Batarseh
BKBrian Kersten
Brian Kersten
APAnna C. Pinelo
Anna C. Pinelo
JNJamie N. Nadler
Jamie N. Nadler
SSStanley A Schwartz
Stanley A Schwartz

16 December 2021 in Pharmacy
Verified
Journal Article
Open access
PDF file
LWLetitia Warunek
Letitia Warunek
NCNicole Cieri-Hutcherson
Nicole Cieri-Hutcherson
BKBrian Kersten
Brian Kersten
AHAmany Hassan
Amany Hassan
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity, mortality, and reduced quality of life for patients. Proper use of inhaler devices is critical for effective drug delivery and prevention of COPD progression. The primary endpoint of this study was a mean percent increase in correct steps associated with inhaler technique after pharmacist education. The co-primary endpoint was a 25% increase in the proportion of patients correctly identifying the appropriate use of short-acting versus long-acting inhaler types. This was an interventional quasi-experimental study of patients hospitalized at a 491-bed tertiary academic medical center with a COPD exacerbation to assess a pharmacist-led COPD care plan. Eligible patients included general floor, adult patients admitted with a primary diagnosis of COPD exacerbation. The primary investigator recorded initial inhaler technique scores through a paper checklist, and provided education about device types and usage. Patients were reassessed within 48 h to determine if pharmacist education improved inhaler knowledge. A total of 67 patients received the COPD care plan before hospital discharge. At baseline, patients scored a median of 81.8% (67.5–97.0) of steps correct across all inhaler device types. After pharmacist education, patient scores increased to a median of 100% (90.9–100.0) (p < 0.0001). The proportion of patients correctly identifying when to use short-acting versus long-acting inhalers increased from 73.1% to 98.5% (p < 0.0001). Implementation of a pharmacist-led care plan for patients admitted for COPD exacerbation was associated with an increase in correct steps for appropriate inhaler technique and understanding of inhaler device types after pharmacist education.

13 February 2024 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
MLMaggie M. Lycouras
Maggie M. Lycouras
NCNicole Cieri-Hutcherson
Nicole Cieri-Hutcherson
BKBrian Kersten
Brian Kersten
CCCollin Clark
Collin Clark

1 March 2021 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
EBEinas Batarseh
Einas Batarseh
BKBrian Kersten
Brian Kersten
APAnna C. Pinelo
Anna C. Pinelo
VVVincent Vertalino
Vincent Vertalino
JNJamie N. Nadler
Jamie N. Nadler
SSStanley A Schwartz
Stanley A Schwartz